Siobhan Dickerson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose: ONC201 is a small-molecule selective antagonist of the G protein-coupled receptor DRD2 that is the founding member of the imipridone class of compounds. A first-in-human phase I study of ONC201 was conducted to determine its recommended phase II dose (RP2D).Experimental Design: This open-label study treated 10 patients during dose escalation with(More)
  • 1